How much does it cost to preserve a larynx? An economic study

European Archives of Oto-Rhino-Laryngology

Volumn 257, Issue 2, 2000, Pages 72-76

  Leon X ^a   Quer, M ^a   Orus C ^a   Lopez Pousa A ^a   Pericay, C ^a   Vega, M ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Chemotherapy; Laryngeal carcinoma; Laryngectomy; Organ preservation; Treatment costs

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; ONDANSETRON;

ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; INTERMETHOD COMPARISON; LARYNX CANCER; MAJOR CLINICAL STUDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0034124719     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007513     Document Type: Article

References (20)

1. 1. Bailey BJ, Stiernberg CM, Quinn FB (1990) Glottic carcinoma. In: Meyers AD, Eiseman B (eds). Cost-effective otolaryngology. Decker, Philadelphia, pp 157-172
2. 2. Bradford CR, Zhu S, Wolf GT, Poore J, Fisher SG, Beals T, McClatchey KD, Carey TE (1995) Overexpession of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group. Otolaryngol Head Neck Surg 113:408-412
3. 3. De Andrés L, Brunet J, López-Pousa A, Burgués J, Quer M, León X, Guedea F, Vega M, Mesía R, López JJ (1995) Function preservation in stage III squamous laryngeal carcinoma: results with an induction chemotherapy protocol. Laryngoscope 105:822-826
4. 4. Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690
5. 5. Ensley JF, Jacobs JR, Weaver A, Kinzie J, Kish JA, Cummings G, Al-Sarraf M (1984) orrelation between response to cisplatinum combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer 54:811-814
6. 6. Finizia C, Geterud Å, Holmberg E, Lindström J, Lundgren J (1996) Advanced laryngeal cancer T3-T4 in Sweden: a retrospective study 1986-1990. Survival and locoregional control related to treatment. Acta Otolaryngol (Stockh) 116:906-912
7. 7. Foote RL, Buskirk SJ, Grado GL, Bonner JA (1997) Has radiotherapy become too expensive to be considered a treatment option for early glottic cancer? Head Neck 19:692-700
8. 8. Marcial VA, Pajak TF, Chang C, Tupchong L, Stetz J (1987) Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Oncology Group (RTOG). Int J Radiat Oncol Biol Phys 13:41-47
9. 9. McDonough EM, Varvares MA, Dunphy FR, Dunleavy T, Dunphy CH, Boyd JH (1996) Changes in quality-of-life scores in a population of patients treated for squamous cell carcinoma of the head and neck. Head Neck 18:487-493
10. 10. McNeil BJ, Weichselbaum R, Pauker SG (1981) Speech and survival. Tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med 305:928-927
11. 11. Million RR, Sigal MC (1994) Cost of management of head and neck cancer. In: Million RR, Cassisi NJ (eds) Management of head and neck cancer: a multidisciplinary approach, 2nd edn. Lippincott, Philadelphia, pp 879-882
12. 12. Million RR, Parsons JT, Cassisi NJ (1985) Twice-a-day irradiation techniques for squamous cell carcinomas of the head and neck. Cancer 55:2096-2099
13. 13. Myers AD (1990) Laryngectomy. In: Meyers AD, Eiseman B (eds). Cost-effective otolaryngology. Decker, Philadelphia, pp 195-202
14. 14. Pfister DG, Strong E, Harrison L, Haines IE, Pfister DA, Sessions R, Spiro R, Shah J, Gerold F, McLure T (1991) Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer. J Clin Oncol 9:850-859
15. 15. Rider WD, Harwood AR (1982) The Toronto philosophy of management in head and neck cancer. J Otolaryngol 11:14-16
16. 16. Shirinian MH, Weber RS, Lippman SM, Lippman SM, Dimery IW, Earley CL, Garden AS, Michaelson J, Morrison WH, Kramer A, Byers R, Peters L, Ki Hong W, Goepfert H (1994) Laryngeal preservation by induction chemotherapy plus radiation in locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience. Head Neck 16:39-44
17. 17. Stewart MG, Chen AY, Stach CB (1998) Outcome analysis of voice and quality of life in patients with laryngeal cancer. Arch Otolaryngol Head Neck Surg 124:143-148
18. 18. Tennvall J, Wennerberg J, Willén R, Ask A, Baldetorp B, Ferno M (1993) T3N0 glottic carcinoma: DNA S-phase as a predictor of the outcome after radiotherapy. Acta Otolaryngol (Stockh) 113:220-224
19. 19. Venegas MP, León X, Quer M, Matiñó E, Montoro V, Burgués J (1997) Complicaciones de la laringectomía total en función del uso previo de radioterapia. Acta Otorrinolaring Esp 48: 639-646
20. 20. Wolf GT, Hong WK (1995) Induction chemotherapy for organ preservation in advanced laryngeal cancer: is there a role? Head Neck 17:279-283